Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054306 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Martina Sandonà und 8 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Fondazione Santa Lucia, 00143 Rome, Italy. Hauptthemen laut MEDLINE: Histone Deacetylases, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Histone deacetylases (HDACs) are enzymes that regulate the deacetylation of numerous histone and non-histone proteins, thereby affecting a wide range of cellular processes. Deregulation of HDAC expression or activity is often associated with several pathologies, suggesting potential for targeting these enzymes for therapeutic purposes. For example, HDAC expression and activity are higher in dystrophic skeletal muscles. General pharmacological blockade of HDACs, by means of pan-HDAC inhibitors (HDACi), ameliorates both muscle histological abnormalities and function in preclinical studies. A phase II clinical trial of the pan-HDACi givinostat revealed partial histological improvement and functional recovery of Duchenne Muscular Dystrophy (DMD) muscles; results of an ongoing phase III clinical trial that is assessing the long-term safety and efficacy of givinostat in DMD patients are pending. Here we review the current knowledge about the HDAC functions in distinct cell types in skeletal muscle, identified by genetic and -omic approaches. We describe the signaling events that are affected by HDACs and contribute to muscular dystrophy pathogenesis by altering muscle regeneration and/or repair processes. Reviewing recent insights into HDAC cellular functions in dystrophic muscles provides new perspectives for the development of more effective therapeutic approaches based on drugs that target these critical enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Fondazione Santa Lucia, 00143 Rome, Italy.
- Unit of Histology and Medical Embryology, Department of Human Anatomy, Histology, Forensic Medicine and Orthopedics, University of Rome "La Sapienza", 00161 Rome, Italy.
- Institute of Nanotechnology, National Research Council (CNR-NANOTEC), University of Rome "La Sapienza", 00181 Rome, Italy.
- Institute of Nanotechnology, National Research Council (CNR-NANOTEC), 73100 Lecce, Italy.
- CNRS UMR 8256, INSERM ERL U1164, Biological Adaptation and Aging B2A, Sorbonne Université, 75005 Paris, France.
- Department of Medicine, Division of Cardiology and Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
ORCID-Profile: Giorgia Cavioli, Alessandra Renzini, Alessia Cedola, Dario Coletti, Viviana Moresi, Valentina Saccone
Förderung
- NHLBI NIH HHS
- NIH HHS
- NIDDK NIH HHS
- AFM Telethon
- Sapienza University of Rome
- National Institutes of Health (NIH)
Zitieren
APA
Sandonà, M., Cavioli, G., Renzini, A., Cedola, A., Gigli, G., Coletti, D., McKinsey, T. A., Moresi, V., & Saccone, V. (2023). Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054306
Vancouver
Sandonà M, Cavioli G, Renzini A, Cedola A, Gigli G, Coletti D, et al. Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054306
BibTeX
@article{Sandon2023,
author = {Sandonà, Martina and Cavioli, Giorgia and Renzini, Alessandra and Cedola, Alessia and Gigli, Giuseppe and Coletti, Dario and McKinsey, Timothy A and Moresi, Viviana and Saccone, Valentina},
title = {Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054306}
}
EUVIMED